Literature DB >> 20810659

Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.

Seiga Ohmine1, Ryuta Sakuma, Toshie Sakuma, Tayaramma Thatava, Gonzalo P Solis, Yasuhiro Ikeda.   

Abstract

TRIM5α is a member of the tripartite motif (TRIM) family of proteins and affects both early and late phases of the retroviral life cycle. Although TRIM5α multimerizes to form cytoplasmic bodies, which are thought to play an important role in viral restriction, the identity of TRIM5α-containing cytoplasmic bodies remains elusive. To better understand TRIM5α cytoplasmic body constituents and the cellular proteins that could be involved in the TRIM5α-mediated antiviral activities, we sought TRIM5α-binding factors. We identified a lipid microdomain protein flotillin-1/Reggie-2 as an interacting partner of TRIM5α via co-immunoprecipitation. Immunohistochemistry studies confirmed the co-localization of rhesus monkey TRIM5α (TRIM5αrh) cytoplasmic bodies with flotillin-1/Reggie-2. Caveolin-1, another lipid microdomain-associated protein, also co-localized with TRIM5α cytoplasmic bodies. Intriguingly, disruption of cellular cholesterol by cyclodextrin perturbed TRIM5α cytoplasmic body formation. Furthermore, lipid starvation partially relieved the endogenous post-entry restriction of HIV-1 infection, which could be subsequently restored by lipid repletion. These observations indicate the involvement of cellular lipids in TRIM5α-mediated antiviral activities. Given that many viruses utilize cellular lipid microdomains for viral entry and assembly, it is plausible that lipid-enriched domains provide microenvironments where TRIM5α recognizes retroviral components.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810659      PMCID: PMC2966066          DOI: 10.1074/jbc.M110.158188

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Reggie/flotillin proteins are organized into stable tetramers in membrane microdomains.

Authors:  Gonzalo P Solis; Maja Hoegg; Christina Munderloh; Yvonne Schrock; Edward Malaga-Trillo; Eric Rivera-Milla; Claudia A O Stuermer
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

3.  No effect of endogenous TRIM5alpha on HIV-1 production.

Authors:  Fengwen Zhang; David Perez-Caballero; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Nat Med       Date:  2008-03       Impact factor: 53.440

Review 4.  The SPFH domain-containing proteins: more than lipid raft markers.

Authors:  Duncan T Browman; Maja B Hoegg; Stephen M Robbins
Journal:  Trends Cell Biol       Date:  2007-09-04       Impact factor: 20.808

5.  Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.

Authors:  Ryuta Sakuma; Josh A Noser; Seiga Ohmine; Yasuhiro Ikeda
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

6.  Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

Authors:  Christian Schmitz; David Marchant; Stuart J D Neil; Keith Aubin; Sandra Reuter; Matthias T Dittmar; Aine McKnight
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Cellular entry of lymphocytic choriomeningitis virus.

Authors:  Jillian M Rojek; Mar Perez; Stefan Kunz
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

8.  Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding.

Authors:  Manfred Frick; Nicholas A Bright; Kirsi Riento; Aurélie Bray; Christien Merrified; Benjamin J Nichols
Journal:  Curr Biol       Date:  2007-07-03       Impact factor: 10.834

9.  Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.

Authors:  Edward M Campbell; Omar Perez; Jenny L Anderson; Thomas J Hope
Journal:  J Cell Biol       Date:  2008-02-04       Impact factor: 10.539

10.  TRIM5 alpha cytoplasmic bodies are highly dynamic structures.

Authors:  Edward M Campbell; Mark P Dodding; Melvyn W Yap; Xiaolu Wu; Sarah Gallois-Montbrun; Michael H Malim; Jonathan P Stoye; Thomas J Hope
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

View more
  5 in total

1.  Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.

Authors:  Seiga Ohmine; Raman Deep Singh; David L Marks; Melissa A Meyer; Richard E Pagano; Yasuhiro Ikeda
Journal:  J Innate Immun       Date:  2013-03-21       Impact factor: 7.349

Review 2.  Ex vivo gene therapy for HIV-1 treatment.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

3.  Enterovirus 71 induces degradation of TRIM38, a potential E3 ubiquitin ligase.

Authors:  Xinlei Liu; Xiaobo Lei; Zhuo Zhou; Zhenmin Sun; Qinghua Xue; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

4.  Sequence Analysis of Macaca mulatta TRIM4 and Its Role in the Interferon Pathway.

Authors:  Mengmeng Zhao; Huawei Li; Hang Zhang; Huiyang Sha; Liangzong Huang; Ruining Wang
Journal:  Front Vet Sci       Date:  2022-02-15

5.  An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.

Authors:  Claire A Schreiber; Toshie Sakuma; Yoshihiro Izumiya; Sara J Holditch; Raymond D Hickey; Robert K Bressin; Upamanyu Basu; Kazunori Koide; Aravind Asokan; Yasuhiro Ikeda
Journal:  PLoS Pathog       Date:  2015-08-05       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.